Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Change in Inventory (2022 - 2025)

Historic Change in Inventory for Zevra Therapeutics (ZVRA) over the last 4 years, with Q3 2025 value amounting to $194000.0.

  • Zevra Therapeutics' Change in Inventory fell 6672.38% to $194000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $5.5 million, marking a year-over-year increase of 3263.34%. This contributed to the annual value of $8.9 million for FY2024, which is 440776.7% up from last year.
  • Zevra Therapeutics' Change in Inventory amounted to $194000.0 in Q3 2025, which was down 6672.38% from $381000.0 recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Change in Inventory ranged from a high of $4.7 million in Q4 2024 and a low of -$241000.0 during Q3 2022
  • In the last 4 years, Zevra Therapeutics' Change in Inventory had a median value of $163500.0 in 2022 and averaged $664357.1.
  • Per our database at Business Quant, Zevra Therapeutics' Change in Inventory plummeted by 11203.01% in 2023 and then surged by 2956875.0% in 2024.
  • Quarter analysis of 4 years shows Zevra Therapeutics' Change in Inventory stood at $133000.0 in 2022, then tumbled by 112.03% to -$16000.0 in 2023, then soared by 29568.75% to $4.7 million in 2024, then plummeted by 95.89% to $194000.0 in 2025.
  • Its Change in Inventory was $194000.0 in Q3 2025, compared to $381000.0 in Q2 2025 and $205000.0 in Q1 2025.